Clinical Trial

Gut Microbiomes in HD

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to find out if there is a connection between the naturally occurring bacteria in our bodies and the progression of Huntington disease. The investigators are trying to determine if patients who are diagnosed with adult-onset HD and who exhibit a rapid rate of disease progression have unique populations of bacteria in their gut as compared to patients with slower progression.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-03; most recent amendment 2025-06-15.
Status change: Not Yet Recruiting → Recruiting 2025-06-15
Trial Details
NCT Number NCT06448546
Lead Sponsor University of Central Florida
Collaborators: University of South Florida
Conditions Huntington Disease
Enrollment 36 participants
Start Date 2025-06
Primary Completion 2027-06 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2025-06-18